Richter And Mithra Extend Estelle To Latin America
Firms Add Chile, Colombia, Ecuador, Mexico And Peru To Partnership
Gedeon Richter and Mithra have expanded their partnership on an in-development contraceptive, Estelle, to cover several Latin American territories on top of Europe and Russia.
You may also be interested in...
Another victim of the COVID-pandemic, Celgene's $9-per-share contingent value right tied to BMS obtaining approval of three drugs goes unrealized due to FDA travel restrictions slowing down site inspections. Clene goes public, United Therapeutics buys PRV from Y-mAbs.
Alvogen is expanding its presence in Asia by licensing a novel oral contraceptive from Belgium’s Mithra and striking a deal to market Orion’s Parkinson’s disease drugs.
Glenmark acquires a portfolio of generic OTCs from Wockhardt marketed in US including famotidine 10- and 20-mgs; cetirizine 5- and 10-mgs; lansoprazole 15-mg delayed-release; and olopatadine hydrochloride 0.1% ophthalmic solution.